Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Tissue Engineered Skin Substitute Market Snapshot (2022 to 2029)

The global Tissue Engineered Skin Substitute Market was valued at US$ 2.01 Billion in 2021 and is expected to reach US$ 4.13 Billion by 2029, finds Future Market Insights (FMI) in a recent market survey.

Data Points Market Insights
Market Value 2022 USD 2.2 Billion
Market Value 2029 USD 4.1 Billion
CAGR 2022 to 2029 9.6%
Key Players The key players are Smith & Nephew plc., Acelity L.P. Inc., Mölnlycke Health Care, Integra Life Sciences, Allergan plc, Regenicin, Organogenesis Inc., MiMedx, LifeNet Health, Kerecis and Medline Industries, Inc.
Share of Top 5 Countries 75.9%

Increasing demand for minimally invasive surgeries, growing geriatric population, growing incidences of diabetic foot ulcers, increasing vascular diseases & burn injuries, development in the healthcare infrastructure, and growing government investment are primary factors expected to boost the tissue-engineered skin substitute market growth.

In addition, the need for tissue-engineered skin substitutes is growing because of the growing occurrence of chronic and acute wounds, great demand for skin grafts, technological advancements in healthcare, and increasing awareness regarding different treatment options.

Tissue Engineered Skin Substitute market holds nearly 5.2% market value share of the US$ 39 Billion Wound Care Management Market in 2021. The market is likewise gaining traction due to the increasing inclination among the population to spend more and choose advanced and new burn care products.

Driven by this, sales of tissue-engineered skin substitutes are expected to rise at a 9.6% CAGR through 2029.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How The Market Progressed Till June 2022?

Particulars Details
H1, 2021 9.04%
H1, 2022 Projected 9.56%
H1, 2022 Outlook 9.46%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 10 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (+) 43 ↑

FMI has provided a comparative analysis of market growth rates and future opportunities in the worldwide tissue-engineered skin substitute market. Regulatory approvals for biomaterials and innovation determinants, as well as the impact of macro and industry dynamics, will have an influence on the market.

Advanced wound therapies include the use of bioengineered artificial skin substitutes and topical release of mesenchymal stem cells to reduce inflammation and speed up the healing process in order to overcome graft rejection. This element accounts for one of the most significant advantages of tissue-generated skin substitutes.

As per the analysis by Future Market Insights, the market is expected to increase by 43 Basis Point Share (BPS) in H1-2022 (O) as compared to H1- 2021. The H1-2022 outlook period in comparison to H1-2022 projected period showed negative growth in terms of Basis Point Share by 10 BPS.

Major reasons for this rise in BPS are attributed to the property of tissue-engineered skin substitutes in providing both epidermal and dermal constituents required to attain functional closure of the wound and have thus been adopted for efficient closure of full-thickness burn wounds, as well as treating burns that are larger than 50% of the total burn surface area.

In the second half of the projection period, other market categories are expected to do fairly well and have excellent growth possibilities. Reduced vascularization, poor mechanical integrity, inability to integrate, scarring, and immunological rejection have all been documented with various commercially available tissue-engineered skin substitutes, all of which are deterrents to the industry's expansion.

Tissue Engineered Skin Substitute Market

2014 to 2021 Tissue Engineered Skin Substitute Market Demand Outlook Compared to 2022 to 2029 Forecast

Sales of tissue engineered skin substitutes grew at a CAGR of 6.4% between 2014 and 2021.

Some of the major factors that are fueling the market development include the growing prevalence of trauma cases, growing burn & chronic wounds, and increasing focus on technological advancements. Moreover, according to the WHO, almost 1.4 million people die from road accidents each year.

In addition, the increasing prevalence of diabetes is anticipated to drive market growth. This is owing to the increased probability of developing a diabetic foot ulcer gradually in diabetic patients. For instance, according to a report published by WHO, the occurrence of diabetes in the global population was estimated to be 9.3% in 2019 and 10.2% in 2030. Hence, as a result, the prevalence of diabetes-associated complications is anticipated to rise over the forecast years.

Moreover, the growing awareness level amongst the population regarding several treatment options is a primary factor boosting the tissue engineered skin substitutes market. The existence of government organizations like non-profit organizations such as the ABA (American Burn Association) and WHO (World Health Organization) similarly add to growing awareness levels.

Considering this, FMI expects the global tissue engineered skin substitute market to grow at a CAGR of 9.6% through 2029.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors Are Restraining Demand for Tissue Engineered Skin Substitute?

Limited awareness among the rural population and the inability to reproduce skin appendages are major factors hindering the growth of tissue engineered skin substitute market. Low awareness regarding the available treatment options for chronic wounds and their possible treatment modalities available in the market among healthcare professionals in rural areas are factors expected to limit the demand for skin substitute products. Limited infrastructure and lack of sophisticated health systems result in less awareness among the people.

The inability of producing skin appendages is one of the key factors that is anticipated to hamper market development sooner rather than later. In addition, increased time consumption for the development of skin substitutes is another factor hampering the market development.

Country-wise Insights

What Makes the USA a Large Market for Tissue Engineered Skin Substitutes?

The USA is estimated to account for around 97.3% of the North American tissue engineered skin substitute market in 2022.

This is mainly owing to the increasing number of burn injuries, technological advancements in the healthcare industry, and the availability of major players in the country. In addition, factors such as the growing occurrence of acute and chronic wounds, modifications in reimbursement policy, and support from the government in the form of finance for the development of innovative wound care products are offering the required drivers for the growth of the market.

Why is Germany Considered a Lucrative Tissue Engineered Skin Substitute Market?

Germany is estimated to account for 27.1% of the Europe tissue engineered skin substitute market in 2022.

The growth drivers for the market in Germany are a huge patient population, high healthcare expenditures, government support for research & development, and accessibility of funds for research. In addition, the increasing incidence of chronic wounds is expected to contribute to the growth of the country.

Underlying diseases, which might result in chronic wounds, such as diabetes or venous diseases, are increasing due to changing lifestyles and are also age-related. It has been observed that the prevalence rate is higher in the population aged over 65 for chronic ulceration. These factors are increasing the demand for wound care which in turn is leading to market development.

What are the Factors Fueling the Demand for Tissue Engineered Skin Substitutes in China?

The tissue engineered skin substitute market in China is estimated to be worth US$ 82.5 Million in 2022 in the global market.

The tissue engineered skin substitute market in China is projected to develop due to growing demand for rapid recovery of wounds and increasing occurrence of chronic wounds and a rise in the number of diabetic foot ulcers.

The pervasiveness of diabetes is found to be increasing in China, as a result, there is rising demand for skin care, so as to decrease the risk of wounds such as diabetic foot ulcers. The occurrence of chronic wounds particularly foot ulcers surges among the diabetic population. Due to this, there is an increasing need for skin substitution such as skin grafting, which is increasing the demand for the overall market.

How will the Tissue Engineered Skin Substitute Market Expand across India?

Demand for tissue engineered skin substitutes in India is expected to rise at around 10.2% CAGR over the forecast period.

India is one of the fastest growing markets in Asia owing to the growing number of road accidents and the subsequent presence of favorable reimbursement policies like National Health Insurance.

India is one of the countries with a high number of road accident cases due to overpopulation and lack of traffic security. According to the Ministry of road transport and Highways, around 4.5 lakh road accidents occur per year in India, out of which 1.5 lakh people die. In addition, burns and traumatic injuries are some of the major factors of acute wounds, which require advanced therapies.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Demand for Biologic Skin Substitute to continue gaining Traction

By-product, biologic skin substitute is anticipated to hold the maximum share of 48.7% in 2022, expanding at a rate of nearly 10.1% during the forecast period.

The biological skin substitutes segment captures the largest market share due to the growing pervasiveness of acute wounds around the globe. The main advantage of biological skin substitutes is that skin is easily accessible from the patient itself. Biological skin substitutes have an additional extracellular matrix that aids in exceptional re-epithelialization and rapid healing of the wound. Such advantages of biological skin substitutes over other substitutes are increasing the demand for the segment.

Why Natural material will hold the most of the market share?

By material, the Natural segment will lead the market and is projected to account for 82.9% of the global market revenue share in 2022.

The advantage provided by natural skin substitutes over other materials is increasing the demand for natural materials in skin substitutes. Natural material can be utilized in situations where sufficient skin grafts are not obtainable, for instance, in extensive burns. Also, this material avoids the formation of additional wounds and also offers a temporary barrier to the wounds until the grafting is completed.

Which application is most sought-after over the forecast period?

By application, chronic wounds will be the most sought-after application and are projected to account for 70.4% of the total market revenue share in 2022.

Expanding penetration of skin substitutes in wound care and treatment of diabetic foot ulcers, and pressure ulcers leads to a high market share of chronic wounds. In addition, the growing demand for breast reconstruction is expected to further strengthen the growth of the market. Also, the increasing geriatric population suffering from diabetes is surging the demand for the tissue engineered skin substitute market.

Why Hospitals projected maximum Growth in the Tissue Engineered Skin Substitute Market?

By end user, the hospital's segment is anticipated to hold the maximum share of 54.1% in 2022, expanding at a rapid rate of 10.0% CAGR during the forecast period.

Hospitals lead among all end users in the market due to the increasing number of surgeries globally. The growing cases of venous leg ulcers and diabetic foot ulcers are the other key factors boosting segment growth. Moreover, the rising number of surgical wound cases owing to the growing number of surgical procedures is adding to the segment growth. Also, the presence of well-developed infrastructure and the availability of advanced equipment supports the development of the segment.

Competitive Landscape

Companies operating in the tissue engineered skin substitute market are fairly competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerate the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market. Some of the recent instances include:

  • In September 2020, MiMedx Group, Inc. announced the launch of EpiCord Expandable, the latest advancement in its portfolio of products. At the core of this technology is EpiCord, which has demonstrated clinical efficacy in the treatment of diabetic foot ulcers.

Scope of the Report

Attributes Details
Forecast Period 2014 to 2021
Historical Data Available for 2022 to 2029
Market Analysis USD Million for Value
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa
Key Segments Covered Product, Material, Application, End User, and Region
Key Companies Profiled
  • Smith & Nephew plc.
  • Acelity L.P. Inc.
  • Mölnlycke Health Care
  • Integra Life Sciences
  • Allergan plc
  • Regenicin
  • Organogenesis Inc.
  • MiMedx
  • LifeNet Health
  • Kerecis
  • Medline Industries, Inc.
Report Coverage Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Tissue Engineered Skin Substitute Market by Category

By Product:

  • Acellular Skin Substitutes
    • Acellular skin substitutes based on Amniotic Membrane
    • Other Acellular skin substitutes
  • Biologic Skin Substitute
    • Allograft
    • Xenograft
  • Cellular Skin Substitutes
    • Cellular skin substitute based on amniotic membrane
    • Other cellular skin substitutes
  • Synthetic Skin Substitutes

By Material:

  • Synthetic
  • Natural

By Application:

  • Chronic Wounds
    • Venous leg Ulcers
    • Diabetic Foot Ulcer
    • Pressure Ulcers
  • Acute Wounds
    • Traumatic Wounds
    • Burn Cases
  • Other Applications

By End User:

  • Hospital
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Research Laboratory

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How much is the Tissue Engineered Skin Substitute market currently worth?

The global tissue engineered skin substitute market is worth US$ 2.01 Billion in 2021 and is set to expand 1.9X over the forecasted years owing to the rising diabetic foot ulcers and growing demand for wound care.

What was last 5 year market CAGR?

The sales of tissue engineered skin substitutes in the market have grown at a CAGR of nearly 6.4% between 2014 and 2021. The need for tissue engineered skin substitutes is growing because of the growing occurrence of chronic and acute wounds, great demand for skin grafts, technological advancements in healthcare, and increasing awareness regarding different treatment options.

What will be demand outlook/sales forecast of Tissue Engineered Skin Substitute market?

The tissue engineered skin substitute market is expected to reach US$ 4.13 Billion by the end of 2029 with sales revenue expected to register a CAGR of 9.6% over the forecast period.

Which is the most lucrative market for Tissue Engineered Skin Substitute market?

North America currently holds the largest market revenue share in the global tissue engineered skin substitute market with 60.9% in 2021. USA is the leading contributor with a market value of over US$ 1.19 Billion in 2022.

At what percentage Tissue Engineered Skin Substitute market is expected to register growth in Europe?

The demand for tissue engineered skin substitute market is expected to register growth in Europe at a rate of 6.7% CAGR during the forecast period.

How likely is the Tissue Engineered Skin Substitute market to grow in China?

The tissue engineered skin substitute market in China is likely to observe growth with an impressive CAGR of 8.4% during the forecast period. The key factors responsible for the growth of the market in China include the need for rapid recovery of wounds and increasing occurrence of chronic wounds and a rise in the number of diabetic foot ulcers.

What are key trends driving sales of Tissue Engineered Skin Substitute?

The introduction of novel designs of skin substitutes, increasing research funding for the development of tissue engineered skin, and an increasing number of mergers and acquisitions are key trends driving sales of tissue engineered skin substitute markets across the globe.

What are the key market statistics in South Korea and Japan?

Japan’s tissue engineered skin substitute market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 7.7% CAGR during the forecast period. The South Korean market is expected to exhibit healthy growth of 6.8% CAGR during the forecast period.

What are the top 5 countries driving demand for Tissue Engineered Skin Substitute market?

The USA, Germany, China, the United Kingdom, and France are the top 5 countries that are driving the demand for tissue engineered skin substitute markets.

Which are leading companies of Tissue Engineered Skin Substitute market?

Leading companies of tissue engineered skin substitutes are Smith & Nephew plc, Acelity L.P. Inc., Mölnlycke Health Care, Integra Life Sciences, Allergan plc, Regenicin, Organogenesis Inc., MiMedx, LifeNet Health, Kerecis and Medline Industries, Inc.

Table of Content

1. Executive Summary | Tissue Engineered Skin Substitute Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Technological Developments

4. Key Success Factors

    4.1. Reimbursement Scenario

    4.2. Regulatory Scenario

    4.3. Pipelined Products

    4.4. Disease Epidemiology

    4.5. Product Characterization

5. Global Market - Pricing Analysis

    5.1. Regional Pricing Analysis By Product Type

    5.2. Global Average Pricing Analysis Benchmark

6. Global Market Analysis 2014 to 2021 and Forecast, 2022 to 2029

    6.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021

    6.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2029

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Market Background

    7.1. Macro-Economic Factors

        7.1.1. Global GDP Growth Outlook

        7.1.2. Global Healthcare Expenditure Outlook

        7.1.3. High Disposable Income

        7.1.4. Reference Pricing

        7.1.5. Healthy Economic Growth In Emerging Countries

    7.2. Forecast Factors - Relevance & Impact

        7.2.1. Increasing Prevalence of Chronic Wound

        7.2.2. Rise in Burn Cases

        7.2.3. Product Approval

        7.2.1. Extensive Network of End Users

        7.2.2. Distribution Channel

    7.3. Market Dynamics

        7.3.1. Drivers

        7.3.2. Restraints

        7.3.3. Opportunity Analysis

8. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Million) Analysis By Product Type, 2014 to 2021

    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product Type, 2022 to 2029

        8.3.1. Acellular Skin Substitutes

            8.3.1.1. Acellular Skin Substitutes Based on Amniotic Membrane

            8.3.1.2. Other Acellular Skin Substitutes

        8.3.2. Biologic Skin Substitutes

            8.3.2.1. Allograft

            8.3.2.2. Xenograft Acellular

        8.3.3. Cellular Skin Substitutes

            8.3.3.1. Cellular Skin Substitutes Based on Amniotic Membrane

            8.3.3.2. Other Cellular Skin Substitutes

        8.3.4. Synthetic Skin Substitutes

    8.4. Market Attractiveness Analysis By Product Type

9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Material

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis By Material, 2014 to 2021

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Material, 2022 to 2029

        9.3.1. Natural

        9.3.2. Synthetic

    9.4. Market Attractiveness Analysis By Material

10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Application, 2014 to 2021

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2029

        10.3.1. Chronic Wounds

            10.3.1.1. Venous Leg Ulcers

            10.3.1.2. Diabetic Foot Ulcers

            10.3.1.3. Pressure Ulcers

        10.3.2. Acute Wounds

            10.3.2.1. Traumatic Wounds

            10.3.2.2. Burn Cases

        10.3.3. Other Applications

    10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By End User, 2014 to 2021

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2029

        11.3.1. Hospital

        11.3.2. Specialty Clinic

        11.3.3. Ambulatory Surgical Center

        11.3.4. Research Laboratory

    11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Million) Analysis By Region, 2014 to 2021

    12.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2029

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Middle East and Africa(MEA)

        12.3.7. Oceania

    12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021

    13.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029

        13.3.1. By Country

            13.3.1.1. USA

            13.3.1.2. Canada

        13.3.2. By Product Type

        13.3.3. By Material

        13.3.4. By Application

        13.3.5. By End User

    13.4. Market Attractiveness Analysis

    13.5. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021

    14.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Product Type

        14.3.3. By Material

        14.3.4. By Application

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021

    15.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. United Kingdom

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product Type

        15.3.3. By Material

        15.3.4. By Application

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021

    16.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Product Type

        16.3.3. By Material

        16.3.4. By Application

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

    16.5. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021

    17.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Product Type

        17.3.3. By Material

        17.3.4. By Application

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

    17.5. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021

    18.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product Type

        18.3.3. By Material

        18.3.4. By Application

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

    18.5. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021

    19.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. South Africa

            19.3.1.3. Rest of Middle East and Africa

        19.3.2. By Product Type

        19.3.3. By Material

        19.3.4. By Application

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

    19.5. Drivers and Restraints - Impact Analysis

20. Emerging Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. India Market Analysis

        20.2.1. Introduction

        20.2.2. Market Value Proportion Analysis by Market Taxonomy

        20.2.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy

            20.2.3.1. By Product Type

            20.2.3.2. By Material

            20.2.3.3. By Application

            20.2.3.4. By End User

        20.2.4. Market Attractiveness Analysis

    20.3. China Market Analysis

        20.3.1. Introduction

        20.3.2. Market Value Proportion Analysis by Market Taxonomy

        20.3.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy

            20.3.3.1. By Product Type

            20.3.3.2. By Material

            20.3.3.3. By Application

            20.3.3.4. By End User

        20.3.4. Market Attractiveness Analysis

    20.4. Brazil Market Analysis

        20.4.1. Introduction

        20.4.2. Market Value Proportion Analysis by Market Taxonomy

        20.4.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy

            20.4.3.1. By Product Type

            20.4.3.2. By Material

            20.4.3.3. By Application

            20.4.3.4. By End User

        20.4.4. Market Attractiveness Analysis

21. Market Structure Analysis

    21.1. Market Share Analysis

    21.2. Market Concentration

    21.3. Competition Mapping

22. Competition Analysis

    22.1. Company Dashboard

    22.2. Company Profile

        22.2.1. Smith & Nephew plc.

            22.2.1.1. Overview

            22.2.1.2. Service Portfolio

            22.2.1.3. Analyst Commentary

        22.2.2. Acelity L.P. Inc.

            22.2.2.1. Overview

            22.2.2.2. Service Portfolio

            22.2.2.3. Analyst Commentary

        22.2.3. Mölnlycke Health Care

            22.2.3.1. Overview

            22.2.3.2. Service Portfolio

            22.2.3.3. Analyst Commentary

        22.2.4. Integra Life Sciences

            22.2.4.1. Overview

            22.2.4.2. Service Portfolio

            22.2.4.3. Analyst Commentary

        22.2.5. Allergan plc

            22.2.5.1. Overview

            22.2.5.2. Service Portfolio

            22.2.5.3. Analyst Commentary

        22.2.6. Regenicin

            22.2.6.1. Overview

            22.2.6.2. Service Portfolio

            22.2.6.3. Analyst Commentary

        22.2.7. Organogenesis Inc.

            22.2.7.1. Overview

            22.2.7.2. Service Portfolio

            22.2.7.3. Analyst Commentary

        22.2.8. MiMedx

            22.2.8.1. Overview

            22.2.8.2. Service Portfolio

            22.2.8.3. Analyst Commentary

        22.2.9. LifeNet Health

            22.2.9.1. Overview

            22.2.9.2. Service Portfolio

            22.2.9.3. Analyst Commentary

        22.2.10. Kerecis

            22.2.10.1. Overview

            22.2.10.2. Service Portfolio

            22.2.10.3. Analyst Commentary

        22.2.11. Medline Industries, Inc.

            22.2.11.1. Overview

            22.2.11.2. Service Portfolio

            22.2.11.3. Analyst Commentary

23. Assumptions and Acronyms Used

24. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 01: Global Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 02: Global Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Material Type

Table 03: Global Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 04: Global Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 05: Global Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region

Table 06: North America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 07: North America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 08: North America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Material

Table 09: North America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 10: North America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 11: Latin America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 12: Latin America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 13: Latin America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Material

Table 14: Latin America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 15: Latin America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 16: Europe Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 17: Europe Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 18: Europe Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Material

Table 19: Europe Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 20: Europe Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 21: South Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 22: South Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 23: South Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Material

Table 24: South Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 25: South Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 26: East Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 27: East Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 28: East Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Material

Table 29: East Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 30: East Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 31: Oceania Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 32: Oceania Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 33: Oceania Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Material

Table 34: Oceania Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 35: Oceania Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 36: MEA Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 37: MEA Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 38: MEA Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Material

Table 39: MEA Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 40: MEA Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 41: India Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 42: India Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, by Material

Table 43: India Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 44: India Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 45: China Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 46: China Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, by Material

Table 47: China Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 48: China Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 49: Brazil Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 50: Brazil Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, by Material

Table 51: Brazil Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 52: Brazil Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 01: Global Cellular Skin Substitutes Based on Amniotic Membrane, Price Difference (US$ Million) By Region, 2022

Figure 02: Global Other Cellular Skin Substitutes (US$ Million) By Region, 2022

Figure 03: Global Acellular Skin Substitutes Based on Amniotic Membrane, Price Difference (US$ Million) By Region, 2022

Figure 04: Global Other Acellular Skin Substitutes (US$ Million) By Region, 2022

Figure 05: Global Biological Skin Substitute (Allograft), Price Difference (US$ Million) By Region, 2022

Figure 06: Global Biological Skin Substitute (Xenograft) (US$ Million) By Region, 2022

Figure 07: Global Synthetic Skin Substitute, Price Difference (US$ Million) By Region, 2022

Figure 08: Global Market Value Analysis (US$ Million), 2014 to 2021

Figure 09: Global Market Value Forecast (US$ Million), 2022 to 2029

Figure 10: Global Devices Market Absolute $ Opportunity, 2022 to 2029

Figure 11: Global Market Share Analysis (%) By Product Type, 2022 & 2029

Figure 12: Global Market Y-o-Y Growth (%) By Product Type, 2022 to 2029

Figure 13: Global Market Attractiveness Analysis, By Product Type

Figure 14: Global Market Share Analysis (%) By Material Type, 2022 & 2029

Figure 15: Global Market Y-o-Y Growth (%) By Material Type, 2022 to 2029

Figure 16: Global Market Attractiveness Analysis, By Material Type

Figure 17: Global Market Share Analysis (%) By Application, 2022 & 2029

Figure 18: Global Market Y-o-Y Growth (%) By Application, 2022 to 2029

Figure 19: Global Market Attractiveness Analysis, By Application

Figure 20: Global Market Share Analysis (%) By End User, 2022 & 2029

Figure 21: Global Market Y-o-Y Growth (%) By End User, 2022 to 2029

Figure 22: Global Market Attractiveness Analysis, By End User

Figure 23: Global Market Share Analysis (%) By Region, 2022 & 2029

Figure 24: Global Market Y-o-Y Growth (%) By Region, 2022 to 2029

Figure 25: Global Market Attractiveness Analysis, By Region

Figure 26: North America Market Value Share, by Country (2022)

Figure 27: North America Market Value Share, by Product (2022)

Figure 28: North America Market Value Share, by Material (2022)

Figure 29: North America Market Value Share, by Application (2022)

Figure 30: North America Market Value Share, by End User (2022)

Figure 31: North America Market Attractiveness Analysis, By Country

Figure 32: North America Market Attractiveness Analysis, By Product Type

Figure 33: North America Market Attractiveness Analysis, By Material

Figure 34: North America Market Attractiveness Analysis, Application

Figure 35: North America Market Attractiveness Analysis, By End User

Figure 36: Latin America Market Value Share, by Country (2022)

Figure 37: Latin America Market Value Share, by Product (2022)

Figure 38: Latin America Market Value Share, by Material (2022)

Figure 39: Latin America Market Value Share, by Application (2022)

Figure 40: Latin America Market Value Share, by End User (2022)

Figure 41: Latin America Market Attractiveness Analysis, By Country

Figure 42: Latin America Market Attractiveness Analysis, By Product Type

Figure 43: Latin America Market Attractiveness Analysis, By Material

Figure 44: Latin America Market Attractiveness Analysis, Application

Figure 45: Latin America Market Attractiveness Analysis, By End User

Figure 46: Europe Market Value Share, by Country (2022)

Figure 47: Europe Market Value Share, by Product (2022)

Figure 48: Europe Market Value Share, by Material (2022)

Figure 49: Europe Market Value Share, by Application (2022)

Figure 50: Europe Market Value Share, by End User (2022)

Figure 51: Europe Market Attractiveness Analysis, By Country

Figure 52: Europe Market Attractiveness Analysis, By Product Type

Figure 53: Europe Market Attractiveness Analysis, By Material

Figure 54: Europe Market Attractiveness Analysis, Application

Figure 55: Europe Market Attractiveness Analysis, By End User

Figure 56: South Asia Market Value Share, by Country (2022)

Figure 57: South Asia Market Value Share, by Product (2022)

Figure 58: South Asia Market Value Share, by Material (2022)

Figure 59: South Asia Market Value Share, by Application (2022)

Figure 60: South Asia Market Value Share, by End User (2022)

Figure 61: South Asia Market Attractiveness Analysis, By Country

Figure 62: South Asia Market Attractiveness Analysis, By Product Type

Figure 63: South Asia Market Attractiveness Analysis, By Material

Figure 64: South Asia Market Attractiveness Analysis, Application

Figure 65: South Asia Market Attractiveness Analysis, By End User

Figure 66: East Asia Market Value Share, by Country (2022)

Figure 67: East Asia Market Value Share, by Product (2022)

Figure 68: East Asia Market Value Share, by Material (2022)

Figure 69: East Asia Market Value Share, by Application (2022)

Figure 70: East Asia Market Value Share, by End User (2022)

Figure 71: East Asia Market Attractiveness Analysis, By Country

Figure 72: East Asia Market Attractiveness Analysis, By Product Type

Figure 73: East Asia Market Attractiveness Analysis, By Material

Figure 74: East Asia Market Attractiveness Analysis, Application

Figure 75: East Asia Market Attractiveness Analysis, By End User

Figure 76: Oceania Market Value Share, by Country (2022)

Figure 77: Oceania Market Value Share, by Product (2022)

Figure 78: Oceania Market Value Share, by Material (2022)

Figure 79: Oceania Market Value Share, by Application (2022)

Figure 80: Oceania Market Value Share, by End User (2022)

Figure 81: Oceania Market Attractiveness Analysis, By Country

Figure 82: Oceania Market Attractiveness Analysis, By Product Type

Figure 83: Oceania Market Attractiveness Analysis, By Material

Figure 84: Oceania Market Attractiveness Analysis, Application

Figure 85: Oceania Market Attractiveness Analysis, By End User

Figure 86: MEA Market Value Share, by Country (2022)

Figure 87: MEA Market Value Share, by Product (2022)

Figure 88: MEA Market Value Share, by Material (2022)

Figure 89: MEA Market Value Share, by Application (2022)

Figure 90: MEA Market Value Share, by End User (2022)

Figure 91: MEA Market Attractiveness Analysis, By Country

Figure 92: MEA Market Attractiveness Analysis, By Product Type

Figure 93: MEA Market Attractiveness Analysis, By Material

Figure 94: MEA Market Attractiveness Analysis, Application

Figure 95: MEA Market Attractiveness Analysis, By End User

Figure 96: India Market Value Analysis (US$ Million), 2014 to 2021

Figure 97: India Market Value Forecast (US$ Million), 2022 to 2029

Figure 98: China Market Value Analysis (US$ Million), 2014 to 2021

Figure 99: China Market Value Forecast (US$ Million), 2022 to 2029

Figure 100: Brazil Market Value Analysis (US$ Million), 2014 to 2021

Figure 101: Brazil Market Value Forecast (US$ Million), 2022 to 2029

Recommendations

Healthcare

Wound Irrigation Systems Market

Published : September 2023

Healthcare

Wound Debridement Products Market

Published : August 2023

Healthcare

Tissue Sealants and Tissue Adhesive Market

Published : June 2022

Healthcare

Tissue Engineered Skin Substitute Market

Published : June 2022

Explore Healthcare Insights

View Reports

Tissue Engineered Skin Substitute Market